Taiwan Advance Bio-Pharmaceutical Inc. (TPEX:4186)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
11.00
-0.05 (-0.45%)
At close: Feb 11, 2026

TPEX:4186 Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
9901,4181,4851,5931,6742,282
Market Cap Growth
-31.46%-4.54%-6.78%-4.84%-26.63%53.00%
Enterprise Value
1,1321,5661,6481,7161,7802,522
Last Close Price
11.0015.7516.5017.7018.6025.35
PE Ratio
43.0061.97-502.52--
PS Ratio
2.664.004.705.016.889.69
PB Ratio
3.925.536.356.516.936.36
P/TBV Ratio
3.925.536.356.617.246.81
P/FCF Ratio
194.04324.592226.39---
P/OCF Ratio
79.44170.23117.78---
EV/Sales Ratio
3.044.425.225.397.3110.70
EV/EBITDA Ratio
17.6627.8071.2855.41--
EV/EBIT Ratio
26.0037.95677.30225.46--
EV/FCF Ratio
221.78358.552470.58---
Debt / Equity Ratio
1.010.901.311.141.030.74
Debt / EBITDA Ratio
3.983.7110.847.81--
Debt / FCF Ratio
50.0152.59460.63---
Net Debt / Equity Ratio
0.560.480.540.500.370.08
Net Debt / EBITDA Ratio
2.422.195.413.91-1.15-0.50
Net Debt / FCF Ratio
27.7428.24187.56-4.35-1.41-0.28
Asset Turnover
0.530.500.430.450.320.32
Inventory Turnover
5.705.475.275.294.834.21
Quick Ratio
0.780.850.740.910.931.35
Current Ratio
0.900.960.821.071.091.61
Return on Equity (ROE)
9.72%9.33%-4.46%1.30%-39.48%-31.18%
Return on Assets (ROA)
3.91%3.62%0.21%0.67%-8.36%-7.14%
Return on Invested Capital (ROIC)
11.04%11.17%0.67%1.88%-28.58%-22.45%
Return on Capital Employed (ROCE)
10.20%9.40%0.60%1.60%-21.90%-13.90%
Earnings Yield
2.36%1.61%-0.72%0.20%-7.08%-3.79%
FCF Yield
0.52%0.31%0.04%-1.75%-3.78%-4.58%
Buyback Yield / Dilution
-----11.05%-6.92%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.